Interviews/Contributions
Investor Insights – Darshana Zaveri -What do you expect to see with funding as we close out 2024
Investor Insights: Darshana Zaveri – What Stage Does Catalyst Typically Invest?
Investor Insights – Darshana Zaveri: Catalyst Health Ventures’ Focus Area
Investor Insights – Darshana Zaveri: How CEOs should prepare for a meeting with CHV
Investor Insights: Louis Cannon – BioStar Capital and their Focus, Stage, and Typical Investment (part 3)
Investor Insights: Alan Davis – BioStar Capital and their Newly Raised Fund (part 2)
Investor Insights: Louis Cannon, MD of BioStar Capital – why were different (part 1)
Investor Insights: Gwen Watanabe – What Do You Look for in New MedTech Ventures?
McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about what her team looks for in prospective partners for new venture opportunities.
Investor Insights: Gwen Watanabe – How Do You See Venture in MedTech Looking in 2023?
McDermott + Bull Partner Ken Dropiewski talks with H.I.G. Capital Managing Director Gwen Watanabe about what she’s expecting to see in the venture capital space in 2023.
